| Contents: |
Machine generated contents note: Introduction -- G. Rosti -- Evidence in favour of single or two courses of high-dose chemotherapy with peripheral blood progenitor cell transplantation in breast cancer -- R.D. Baynes, W.P. Peters and M. Hernandez-Bronchud -- The importance of dose and time in the treatment of breast cancer -- D.A. Cameron and R.C.F. Leonard -- Long-term disease-free survival in disseminated breast cancer patients treated with conventional and high-dose chemotherapy: -- Predictive factors and therapeutic implications -- M. Martin, A. Casado, L. Llorente, I Garcia Carbonero, -- J.A. Garcia Saenz and E. Diaz-Rubio -- High-dose chemotherapy with progenitor cell rescue in patients with lymphomas and solid tumours: What is believed and what is known? -- D.K. Hossfeld -- Dose and time: A crucial factor in high-grade lymphoma -- M. Reiser, V. Diehl and A. Engert -- The importance of dose and time: Example of testicular cancer -- S. Culine -- Ongoing studies and the EBMT database -- G. Rosti, P. Ferrante, J.L. Pico, S. Leyvraz, J. Crown, R. Ladenstein, -- H. Roch, P. Biron, P. Viens, D. Niederwieser, F. Chauvin, -- E. Koscelniak, J. Ledermann and M. Marangolo -- Timely chemotherapy in lung cancer: The proper dose at the proper time -- T.A.W. Splinter -- The importance of dose and time: Example of soft tissue sarcoma and osteosarcoma -- H. Dumez and A.T. van Oosterom -- Is chemotherapy dose an important determinant of treatment outcome? -- M. Hernandez-Bronchud -- Subject index. |
Cite/Export
Preview this item